CARDIOLOGY / CLINICAL RESEARCH
A worsened prognosis for patients after stroke with newly diagnosed atrial fibrillation compared to having a preexisting arrhythmia
More details
Hide details
1
Clinic of Neurology, Swietokrzyskie Neurology Center, Kielce, Poland
2
Faculty of Medical and Health Sciences, University of Jan Kochanowski, Kielce, Poland
3
Department of Internal Diseases and Diabetology, Hospital St. Alexander, Kielce, Poland
4
1st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center, Kielce, Poland
Submission date: 2022-03-30
Final revision date: 2022-07-06
Acceptance date: 2022-07-25
Online publication date: 2022-08-03
Corresponding author
Iwona Gorczyca-Głowacka
Faculty of Medical
and Health Sciences
The University of Jan Kochanowski
IX Wieków Kielc 19 A
25-317 Kielce, Poland
Arch Med Sci 2025;21(3):757-765
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Atrial fibrillation (AF) is a major cause of ischemic stroke. Patients with undiagnosed AF lack the stroke prevention provided by oral anticoagulants. The aim of this study was to compare the in-hospital mortality rate between ischemic stroke patients diagnosed with AF de novo and ischemic stroke patients diagnosed with AF prior to hospitalization for stroke.
Material and methods:
We identified patients admitted to the Neurology Center during the years 2013–2014 with acute ischemic stroke and AF. We analyzed in-hospital outcomes in patients with newly diagnosed AF and those with known AF. The study endpoint was death during hospitalization.
Results:
The study included 2,000 patients with acute ischemic stroke, out of whom 579 patients (29%) were diagnosed with AF. AF was newly diagnosed in 123 patients (21.2%) (new-AF group), while 456 patients (78.8%) had a history of AF (previous-AF group). The mean National Institutes of Health Stroke Scale (NIHSS) score at admission was 7.2 points in the new-AF group and 3.7 in the previous-AF group (p < 0.001). In-hospital death was more common in the new-AF group (13 patients, 10.6%) than in the previous-AF group (16 patients, 3.5%) (p = 0.003). In multivariate analysis, the NIHSS score at admission in the new-AF group was associated with higher mortality, while in the previous-AF group, the NIHSS score at admission and multiple ischemic foci were risk factors of in-hospital mortality.
Conclusions:
Newly diagnosed AF in ischemic stroke patients significantly worsens prognosis compared to patients previously diagnosed with AF. Early detection of latent AF and subsequent use of anticoagulation are important in preventing severe stroke.
REFERENCES (29)
1.
Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 2007; 4: S1-6.
2.
Boysen G, Nyboe J, Appleyard M, et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988; 19: 1345-53.
3.
Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-9.
4.
Petersen P, Kastrup J, Videbaek R, Boysen G. Cerebral blood flow before and after cardioversion of atrial fibrillation. J Cereb Blood Flow Metab 1989; 9: 422-5.
5.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-8.
6.
Staszewski J, Wąsek W. [Secondary prevention of cardiogenic stroke in nonvalvular atrial fibrillation]. Neurologia po Dyplomie 2016: 11: 21-35.
7.
Alberts M, Chen YW, Lin JH, Kogan E, Twyman K, Milentijevic D. Risks of stroke and mortality in atrial fibrillation patients treated with rivaroxaban and warfarin. Stroke 2020; 51: 549-55.
8.
Wańkowicz P, Staszewski J, Dębiec A, Nowakowska-Kotas M, Szylińska A, Rotter I. Ischemic stroke risk factors in patients with atrial fibrillation treated with new oral anticoagulants. J Clin Med 2021; 10: 1223.
9.
Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complication in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 1: 175-9.
10.
Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-55.
11.
Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-9.
12.
Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham study. Stroke 1996; 27: 1760-4.
13.
Pastuszak Ż, Koźniewska E, Stępień A, Piusińska-Macoch A, Czernicki Z, Koszewski W. Importance rating of risk factors of ischemic stroke in patients over 85 years old in the polish population. Neurol Neurochir Pol 2018; 52: 88-93.
14.
Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-420.
15.
Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-9.
16.
Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 2013; 127: 930-7.
17.
Roche F, Gaspoz JM, Da Costa A, et al. Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-Hour Holter. Pacing Clin Electrophysiol 2002; 25: 1587-93.
18.
Jaakkola J, Mustonen P, Kiviniemi T, et al. Stroke as the first manifestation of atrial fibrillation. PLoS One 2016; 11: e0168010.
19.
Lin HJ, Wolf PA, Benjamin EJ, Belanger AJ, D’Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham study. Stroke 1995; 26: 1527-30.
20.
Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke 1993; 24: 26-30.
21.
Borowsky LH, Regan S, Chang Y, Ayres A, Greenberg SM, Singer DE. First diagnosed of atrial fibrillation at the time of stroke. Cerebrovasc Dis 2017; 43: 192-9.
22.
Ong CT, Wong YS, Sung SF, et al. Sex-related differences in the risk factors for in-hospital mortality and outcomes of ischemic stroke patients in rural areas of Taiwan. PLoS One 2017; 12: e0185361.
23.
Steger C, Pratter A, Martinek-Bregel M, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke Registry. Eur Heart J 2004; 25: 1734-40.
24.
Kongbunkiat K, Kasemsap N, Travanichakul S, Thepsuthammarat K, Tiamkao S, Sawanyawisuth K. Hospital mortality from atrial fibrillation associated with ischemic stroke: a national data report. Int J Neurosci 2015; 125: 924-8.
25.
Deguchi I, Hayashi T, Fukuoka T, Kobayashi S, Tanahashi N; Japan Standard Stroke Registry Study Group. Features of cardioembolic stroke with persistent and paroxysmal atrial fibrillation – a study with the Japan Stroke Registry. Eur J Neurol 2015; 22: 1215-9.
26.
Tu HT, Campbell BC, Meretoja A, et al. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis 2013; 36: 273-80.
27.
Li S, Zhao X, Wang C, et al. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation. J Stroke Cerebrovasc Dis 2013; 22: 419-25.
28.
Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478-86.
29.
Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014; 129: 2094-9.